Practical update of total dose compensation in case of temporary interruption of external radiotherapy in the COVID-19 pandemic context
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Cancer/Radiothérapie
- Vol. 24 (3), 182-187
- https://doi.org/10.1016/j.canrad.2020.04.001
Abstract
No abstract availableKeywords
Funding Information
- Université de Montpellier
This publication has 33 references indexed in Scilit:
- Time to Adjuvant Radiotherapy in Breast Cancer Affects Survival: Implications for the American College of Surgeons Commission on Cancer Quality MetricsAnnals of Surgical Oncology, 2020
- Chemoradiotherapy of locally-advanced non-small cell lung cancer: Analysis of radiation dose–response, chemotherapy and survival-limiting toxicity effects indicates a low α/β ratioRadiotherapy and Oncology, 2020
- Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapyRadiotherapy and Oncology, 2020
- Significance of overall concurrent chemoradiotherapy duration on survival outcomes of stage IIIB/C non-small-cell lung carcinoma patients: Analysis of 956 patientsPLOS ONE, 2019
- The alfa and beta of tumours: a review of parameters of the linear-quadratic model, derived from clinical radiotherapy studiesRadiation Oncology, 2018
- Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancerJournal of Medical Imaging and Radiation Oncology, 2017
- Effect of radiotherapy delay in overall treatment time on local control and survival in head and neck cancer: Review of the literatureReports of Practical Oncology and Radiotherapy, 2015
- The role of overall treatment time in the outcome of radiotherapy of prostate cancer: An analysis of biochemical failure in 4839 men treated between 1987 and 1995Radiotherapy and Oncology, 2010
- Impact of Concurrent Versus Sequential Tamoxifen With Radiation Therapy in Early-Stage Breast Cancer Patients Undergoing Breast Conservation TreatmentJournal of Clinical Oncology, 2005
- The effect of increasing the treatment time beyond three weeks on the control of T2 and T3 laryngeal cancer using radiotherapyRadiotherapy and Oncology, 1992